AAV9-GLA restores α-galactosidase levels in murine model of Fabry disease
May 25, 2023
Fabry disease is a metabolic disease characterized by a deficiency in the lysosomal α-galactosidase enzyme caused by mutations in the GLA gene. This leads to substrate accumulation in the lysosomes, cellular dysfunction and organ damage.